Search results for "decision"

showing 10 items of 2091 documents

Antiviral therapy in the palliative setting of HCC (BCLC-B and -C)

2020

The potential impact of direct-acting antivirals (DAAs) in patients with Barcelona Clinic Liver Cancer (BCLC)-B/C stage hepatocellular carcinoma (HCC) is understudied. Patients with HCC have been systematically excluded from randomised controlled trials evaluating the effectiveness of DAAs. Thus, the benefits of DAAs in patients with HCC are less well defined. The presence of active HCC before the initiation of DAA treatment is reported to be a predictor of DAA failure, and studies in patients without HCC have demonstrated that improvements in cirrhosis complications were lower or absent after DAA failure. Even if viral eradication is achieved using DAAs, reversal of liver function impairme…

0301 basic medicinemedicine.medical_specialtyCirrhosisrecurrenceCarcinoma Hepatocellularmedicine.medical_treatmentDecision MakingLiver transplantationAntiviral AgentsRisk Assessment03 medical and health sciences0302 clinical medicineMedicineHumansStage (cooking)HCCIntensive care medicineDAANeoplasm StagingAntiviral Agent...Hepatologybusiness.industryLiver NeoplasmsPalliative CareCancerHepatitis C Chronicmedicine.diseaseBCLC Stage030104 developmental biologyBCLC-Dliver functionHepatocellular carcinoma030211 gastroenterology & hepatologyLiver functionbusinessLiver cancerBCLC-BBCLC-CHuman
researchProduct

The Unsolved Conundrum of Optimal Blood Pressure Target During Acute Haemorrhagic Stroke: A Comprehensive Analysis

2019

Intracerebral haemorrhage (ICH) is a devastating cerebrovascular disease, which accounts to 15% of all strokes. Among modifiable risk factors for ICH, hypertension is the most frequent. High blood pressure (BP) is detected in more than 75–80% of patients with ICH. Extremely elevated BP has been associated with early hematoma growth, a relatively frequent occur-rence and powerful predictor of poor outcome in patients with spontaneous ICH. On the other hand, excessively low BP might cause cerebral hypoperfusion and ultimately lead to poor outcome. This review will analyse the most important trials that have tried to establish how far should BP be lowered during acute ICH. These trials have de…

0301 basic medicinemedicine.medical_specialtySettore MED/09 - Medicina InternaElevated bpClinical Decision-MakingBlood PressureHaemorrhagic stroke03 medical and health sciences0302 clinical medicinePharmacotherapyHematomaRisk FactorsInternal medicineInternal MedicinemedicineHumansIn patientcardiovascular diseasesStrokeAntihypertensive AgentsCerebral HemorrhageSettore MED/14 - NefrologiaCerebral hypoperfusionBlood pressure · Hypertension · Intracerebral haemorrhage · Strokebusiness.industrymedicine.diseaseStrokeTreatment Outcome030104 developmental biologyBlood pressureCardiologySettore MED/26 - NeurologiaCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgery
researchProduct

Liquid Biopsy in Gastrointestinal Stromal Tumor

2017

Over the past 15 years, gastrointestinal stromal tumors (GISTs) have emerged from a poorly understood neoplasm to a well-defined tumor entity. Starting from 2000, the discovery of gain-of-function mutations involving KIT or PDGFRα (platelet-derived growth factor-α) genes and the development of tyrosine kinase inhibitors (TKIs), such as imatinib, revolutionized dramatically the management of GISTs. Due to the almost continual emergence of new data about biological complexity of GISTs and more sophisticated whole-genome technologies, to date, the role of molecular biology is clinically important to drive therapeutic decision making.

0301 basic medicinemedicine.medical_specialtyStromal cellbusiness.industryGeneral surgeryImatinibTherapeutic decision makingmedicine.diseasedigestive system diseases03 medical and health sciences030104 developmental biology0302 clinical medicine030220 oncology & carcinogenesisCancer researchMedicineNeoplasmGastrointestinal stromal tumors (GISTs)Liquid biopsyStromal tumorbusinessneoplasmsTyrosine kinasemedicine.drug
researchProduct

Clinical Decision-Making when Treating Diabetic Macular Edema Patients with Dexamethasone Intravitreal Implants.

2017

Diabetes mellitus (DM) is a metabolic disease frequently associated with comorbidities that include diabetic macular edema (DME). The current medical approach to treating DME involves intravitreal injections with either anti-vascular endothelial growth factors or steroids. However, the burden associated with intravitreal injections and DM-derived complications is high, underlining the need to find optimal treatment regimens. In this article we describe the considerations we apply when treating DME patients with dexamethasone intravitreal implants (Ozurdex®), particularly those that influence the clinical decision-making process during the follow-up period. These considerations are based bot…

0301 basic medicinemedicine.medical_specialtyVisual acuitygenetic structuresClinical Decision-MakingVisual AcuityDexamethasoneMacular Edema03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusDexamethasone Intravitreal ImplantMedicineHumansMacular edemaGlucocorticoidsDexamethasoneDrug ImplantsDiabetic Retinopathybusiness.industryGeneral MedicineDiabetic retinopathymedicine.diseaseeye diseasesSensory SystemsPathophysiologyOphthalmology030104 developmental biologyIntravitreal Injections030221 ophthalmology & optometrymedicine.symptombusinessTomography Optical Coherencemedicine.drugMedical literatureOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
researchProduct

The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylo…

2016

International audience; Objectives - To develop and validate a prediction score, to quantify, within 48 h of Staphylococcus aureus bacteremia (SAB) diagnosis, the risk of IE, and therefore determine priority for urgent echocardiography. Methods - Consecutive adult patients with SAB in 8 French university hospitals between 2009 and 2011 were prospectively enrolled and followed-up 3 months. A predictive model was developed and internally validated using bootstrap procedures. Results - Among the 2008 patients enrolled, 221 (11.0%) had definite IE of whom 39 (17.6%) underwent valve surgery, 25% of them within 6 days of SAB diagnosis. Ten predictors independently associated with IE were used to …

0301 basic medicinemedicine.medical_treatmentBacteremiaHospitals University0302 clinical medicine[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyInterquartile rangeVertebral osteomyelitis030212 general & internal medicineLongitudinal StudiesProspective StudiesChildbiologyEndocarditisHeartMiddle AgedStaphylococcal InfectionsImplantable cardioverter-defibrillator3. Good healthInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyEchocardiographyInfective endocarditisChild PreschoolPrognostic scoreFranceMeningitisVIRSTA scoreMicrobiology (medical)Adultmedicine.medical_specialtyStaphylococcus aureusAdolescent030106 microbiologyRisk AssessmentDecision Support Techniques03 medical and health sciencesYoung AdultInternal medicinemedicineHumans[SDV.MP] Life Sciences [q-bio]/Microbiology and ParasitologyAgedbusiness.industryC-reactive proteinmedicine.diseaseConfidence intervalSurgeryBacteremiabiology.proteinInfective endocarditisStaphylococcus aureus bacteremiabusiness
researchProduct

Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal

2020

Clinicians in molecular tumor boards (MTB) are confronted with a growing amount of genetic high-throughput sequencing data. Today, at German university hospitals, these data are usually handled in complex spreadsheets from which clinicians have to obtain the necessary information. The aim of this work was to gather a comprehensive list of requirements to be met by cBioPortal to support processes in MTBs according to clinical needs. Therefore, oncology experts at nine German university hospitals were surveyed in two rounds of interviews. To generate an interview guideline a scoping review was conducted. For visual support in the second round, screenshot mockups illustrating the requirements …

0301 basic medicinerequirements analysisdecision making computer-assistedComputer scienceprecision medicineClinical BiochemistrySequencing dataneoplasmsdecision support systems clinicalmolecular tumor boardArticleGerman03 medical and health sciencescomputational biology0302 clinical medicineMedizinische FakultätTumor boardddc:610Requirements analysislcsh:R5-920GuidelinePrecision medicineUniversity hospitallanguage.human_languagecBioPortalEngineering management030104 developmental biologyWork (electrical)030220 oncology & carcinogenesislanguagelcsh:Medicine (General)Diagnostics
researchProduct

Improving the Translational Medicine Process: Moving Patients From "End-Users" to "Engaged Collaborators".

2019

Translational medicine works through the definition of unmet medical needs, their understanding and final resolution. In this complex and multi-disciplinary process patients have always been regarded as "end-users" or no more than "data provider." Considering that the translational practice is nowadays highly inefficient (i.e., large intellectual and economical resources are wasted with limited impact on people health) here we propose to reverse the process: start from patients, engage them, and keep them at the center. A new partnership needs to be formed between the patients and the health care professionals, as well as the treating physicians, to make the most out of the current "health …

030213 general clinical medicineProcess (engineering)Patient advocacythe innovation journey03 medical and health sciences0302 clinical medicinetranslational medicineHealth careJournal Article030212 general & internal medicineshared decision medicinelcsh:R5-920business.industryEnd userpatient-centric approachesTranslational medicineData providerGeneral MedicinePublic relationspatient advocacyPatient centricGeneral partnershipPerspectiveMedicinebusinesslcsh:Medicine (General)Frontiers in medicine
researchProduct

The Impact of Artificial Intelligence on Traditional Chinese Medicine

2021

Traditional Chinese Medicine (TCM) is a well-established medical system with a long history. Currently, artificial intelligence (AI) is rapidly expanding in many fields including TCM. AI will significantly improve the reliability and accuracy of diagnostics, thus increasing the use of effective therapeutic methods for patients. This systematic review provides an updated overview on the major breakthroughs in the field of AI-assisted TCM four diagnostic methods, syndrome differentiation, and treatment. AI-assisted TCM diagnosis is mainly based on digital data collected by modern electronic instruments, which makes TCM diagnosis more quantitative, objective, and standardized. As a result, th…

0303 health sciencesEvidence-Based MedicineDiagnostic methodsElectronic instrumentComputer sciencebusiness.industryClinical Decision-MakingGeneral MedicineTraditional Chinese medicineScientific revolutionScientific evidence03 medical and health sciences0302 clinical medicineComplementary and alternative medicineArtificial IntelligenceHumansClinical efficacyArtificial intelligenceMedicine Chinese TraditionalbusinessSyndrome differentiation030217 neurology & neurosurgery030304 developmental biologyWestern medicineThe American Journal of Chinese Medicine
researchProduct

Defining classifier regions for WSD ensembles using word space features

2006

Based on recent evaluation of word sense disambiguation (WSD) systems [10], disambiguation methods have reached a standstill. In [10] we showed that it is possible to predict the best system for target word using word features and that using this 'optimal ensembling method' more accurate WSD ensembles can be built (3-5% over Senseval state of the art systems with the same amount of possible potential remaining). In the interest of developing if more accurate ensembles, w e here define the strong regions for three popular and effective classifiers used for WSD task (Naive Bayes – NB, Support Vector Machine – SVM, Decision Rules – D) using word features (word grain, amount of positive and neg…

0303 health sciencesProbability learningWord-sense disambiguationComputer sciencebusiness.industryPattern recognition02 engineering and technologyDecision ruleSupport vector machine03 medical and health sciencesNaive Bayes classifier0202 electrical engineering electronic engineering information engineering020201 artificial intelligence & image processingStatistical analysisArtificial intelligencePolysemybusinessClassifier (UML)030304 developmental biology
researchProduct

Loss of habitats, naturalness and species diversity in Eurasian forest landscapes

2010

Abstract Man has exploited land and forests in Western and Central Europe longer and more intensively than in Northern Europe and further east in Eurasia. We estimated forest naturalness and modelled expected biodiversity loss in seven different landscapes (2500 km2 each) in the Netherlands, Sweden, Finland, Poland, St. Petersburg (Western European Russia), Perm (Eastern European Russia), and Irkutsk (Central Siberia) across the distribution of Pinus sylvestris L. in Eurasia. Field inventories showed that the mean living tree volumes were relatively similar in the studied sites, but the volumes of dead wood differed greatly. In Irkutsk and Perm the volume of dead trees per ha was about 5–10…

040101 forestry0106 biological sciencesExtinctionEcologybusiness.industryEcologyBiodiversityGeneral Decision SciencesDistribution (economics)Species diversityDead woodForestry04 agricultural and veterinary sciences15. Life on land010603 evolutionary biology01 natural sciencesEastern europeanGeographyHabitat destructionHabitat0401 agriculture forestry and fisheriesbusinessEcology Evolution Behavior and SystematicsEcological Indicators
researchProduct